RT Journal Article
SR Electronic
T1 GRAPPA 2013 Basic/Translational/Clinical Science Update: Comorbidity Monitoring
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 1224
OP 1226
DO 10.3899/jrheum.140175
VO 41
IS 6
A1 Wolf-Henning Boehncke
YR 2014
UL http://www.jrheum.org/content/41/6/1224.abstract
AB It is now well established that psoriatic disease is associated with increased cardiovascular (CV) risk. Screening guidelines and expert recommendations for CV risk factors have been published, but these are primarily directed to specific specialists (e.g., cardiologists or diabetologists) and may not be well known in common practice. The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and other organizations are interested in adapting current comorbidity screening guidelines for use by dermatologists and rheumatologists. The resulting checklists and algorithms will need to be evaluated for practicability and performance.